Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04671680 · ClinicalTrials.gov registry record
CNAP vs IABP in Pregnant Women With Placenta Accreta
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- 20
- Enrollment target
NCT04671680 is a clinical trial that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT04671680 was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to investigate a technique to monitor blood pressure in women undergoing cesarean delivery with suspected placenta accreta spectrum. To achieve this objective, the investigators plan to conduct a prospective, observational study with the following aims: Specific Aim 1: Compare concordance between the systolic (SBP), diastolic (DBP), and mean arterial blood pressure (MAP) readings from the continuous non-invasive arterial blood pressure (CNAP) and IABP at several discrete points throughout the procedure Specific Aim 2: Determine the feasibility of using CNAP to aid in decision making by examining the parameters of volume responsiveness and arterial elastance at several discrete points throughout the procedure. The investigators hypothesize that the investigators can obtain similar blood pressure monitoring using CNAP as compared to the gold standard IABP in women undergoing cesarean delivery with suspected placenta accreta.
Interventions
- DEVICE LiDCO CNAP Monitoring Equipment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2025-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04671680
The ClinicalTrials.gov registry entry for NCT04671680 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LiDCO CNAP Monitoring Equipment is the first listed.
NCT04671680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04671680 about?
NCT04671680 is a clinical study titled "CNAP vs IABP in Pregnant Women With Placenta Accreta". The objective of this study is to investigate a technique to monitor blood pressure in women undergoing cesarean delivery with suspected placenta accreta spectrum. To achieve this objective, the investigators plan to conduct a prospective, observational study with the following aims: Specific Aim 1...
What is the current status of trial NCT04671680?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2021-01-15. Estimated completion is 2025-06-01.
What interventions are being tested in trial NCT04671680?
The interventions under investigation include: LiDCO CNAP Monitoring Equipment (DEVICE).
Who is sponsoring clinical trial NCT04671680?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.